BRKR
NASDAQ · Life Sciences Tools & Services
Bruker Corp
$63.28
-0.90 (-1.40%)
Financial Highlights (FY 2026)
Revenue
3.41B
Net Income
-8,542,531
Gross Margin
47.1%
Profit Margin
-0.3%
Rev Growth
+10.7%
D/E Ratio
0.76
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 47.1% | 47.1% | 67.6% | 67.6% |
| Operating Margin | 1.4% | 1.3% | 13.4% | 14.0% |
| Profit Margin | -0.3% | -0.2% | 11.5% | 12.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 3.41B | 3.08B | 1.92B | 2.28B |
| Gross Profit | 1.61B | 1.45B | 1.30B | 1.54B |
| Operating Income | 47.75M | 38.81M | 256.32M | 318.62M |
| Net Income | -8,542,531 | -6,942,638 | 220.32M | 272.46M |
| Gross Margin | 47.1% | 47.1% | 67.6% | 67.6% |
| Operating Margin | 1.4% | 1.3% | 13.4% | 14.0% |
| Profit Margin | -0.3% | -0.2% | 11.5% | 12.0% |
| Rev Growth | +10.7% | +10.7% | +23.7% | -3.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.09B | 2.09B | 752.51M | 754.20M |
| Total Equity | 2.75B | 2.75B | 2.63B | 2.39B |
| D/E Ratio | 0.76 | 0.76 | 0.29 | 0.32 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 266.49M | 228.61M | 370.66M | 419.03M |
| Free Cash Flow | — | — | 246.46M | 325.34M |